Supreme Court deals blow to ObamaCare contraception mandate


The Supreme Court on Monday ruled that some companies with religious objections can be exempt from ObamaCare's contraception mandate, delivering a victory to the religious right while dealing a potentially serious blow to the health care law.
In a 5-4 decision, the justices ruled that "closely held corporations cannot be required to provide contraception coverage" for their employees, according to SCOTUSBlog. Writing for the majority in the the case, Justice Samuel Alito said the government had failed to prove the mandate was the most effective — and least intrusive — way to guarantee access to birth control for all women.
At issue was whether the federal government could compel for-profit companies to pay for contraceptive coverage for their employees. The two businesses that brought the case, Hobby Lobby and Conestoga Wood Specialties, argued that the mandate violated their religious liberty, and that they should be exempt.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Crucially though, the plaintiffs did not argue that the entire mandate should be tossed. Hence, the ruling was relatively narrow, with the high court declining to strike down the mandate wholesale, and adding that women effected by the ruling may still get free, government-subsidized contraceptive coverage.
Still, the decision could have wide-ranging implications. Several dozen other for-profit companies have filed suits challenging the mandate. Given the crux of the ruling, more could now try to claim the religious exemption, too.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jon Terbush is an associate editor at TheWeek.com covering politics, sports, and other things he finds interesting. He has previously written for Talking Points Memo, Raw Story, and Business Insider.
-
Tuberculosis is seeing a resurgence, and it's only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US Published
-
Crossword: April 3, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: April 3, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published